
|Articles|August 1, 2016
CTTI Recommends New Vaccine Approaches
The Clinical Trials Transformation Initiative (CTTI) have released recommendations for hospital acquired and ventilator-associated bacterial pneumonia (HABP/VABP) as part of its antibacterial drug development program.
Advertisement
The Clinical Trials Transformation Initiative (CTTI) have released recommendations for hospital acquired and ventilator-associated bacterial pneumonia (HABP/VABP) as part of its antibacterial drug development program. The recommendations outline clinical trial approaches such as early enrollment strategies and streamlining the collection of safety data.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5



